Extracorporeal Membrane Oxygenation Application in Children

Öz

Extracorporeal membrane oxygenation (ECMO) is an advanced treatment for patients with failing heart and lung function. Especially in cases of cardiorespiratory failure that do not respond to conventional treatment methods, ECMO can increase patients' chances of survival by supporting the function of vital organs. ECMO therapy is used in a wide range of patients from newborns to adults. In newborns, effective results can be obtained especially in cases such as respiratory distress, congenital heart diseases and meconium aspiration, while in adults, it is successfully applied in diseases such as severe cardiopulmonary failure, viral infections such as COVID-19 and severe pulmonary embolism. Over time, technological advances in ECMO devices and increased clinical experience have increased the effectiveness of the treatment and expanded its area of use. The effectiveness of ECMO depends on factors such as the general health status of the patient, the likelihood of response to treatment and the reversibility of the disease. Therefore, the success of ECMO therapy is directly related to correct patient selection and timely intervention. A multidisciplinary approach and the role of an expert ECMO team are crucial for the successful implementation of this treatment modality.

Anahtar Kelimeler

• Child
• extracorporeal membrane oxygenation
• cardiopulmonary support

Çocuklarda Ekstrakorporeal Membran Oksijenasyon Uygulaması

Öz

Ekstrakorporeal membran oksijenasyonu (ECMO), kalp ve akciğer fonksiyonları yetersiz kalan hastalar için uygulanan, ileri düzey bir tedavi yöntemidir. Özellikle geleneksel tedavi yöntemlerine yanıt vermeyen kardiyorespiratuar yetmezlik durumlarında, ECMO, hayati organların fonksiyonlarını destekleyerek hastaların yaşama şansını artırabilir. ECMO tedavisi, yenidoğanlardan yetişkinlere kadar geniş bir hasta grubunda kullanılmaktadır. Yenidoğanlarda özellikle solunum distressi, konjenital kalp hastalıkları ve mekonyum aspirasyonu gibi durumlarda etkin sonuçlar elde edilebilirken, yetişkinlerde de ciddi kardiyopulmoner yetmezlik, COVID-19 gibi viral enfeksiyonlar ve ağır pulmoner emboli gibi hastalıklarda başarıyla uygulanmaktadır. Zaman içinde ECMO cihazlarındaki teknolojik gelişmeler ve klinik deneyimin artması, tedavinin etkinliğini artırmış ve kullanım alanını genişletmiştir. ECMO’nun etkinliği, hastanın genel sağlık durumu, tedaviye yanıt verme olasılığı ve hastalığın geri döndürülebilirliği gibi faktörlere bağlıdır. Bu nedenle, ECMO tedavisinin başarısı, doğru hasta seçimi ve zamanında müdahale ile doğrudan ilişkilidir. Bu tedavi yönteminin başarıyla uygulanabilmesi için multidisipliner bir yaklaşım ve uzman bir ECMO ekibinin rolü oldukça önemlidir.

Anahtar Kelimeler

• Çocuk
• Ekstrakorporeal Membran Oksijenasyonu
• Kardiyopulmoner Destek

Kaynakça

1. 1. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minnesota Medicine. 1954;37(3):171-180.
2. 2. Hill JD. Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). New England Journal of Medicine. 1972;286:629-634.
3. 3. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. ASAIO Journal. 1976;22(1):80-92.
4. 4. Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organization registry international report 2016. ASAIO Journal. 2017;63(1):60-67.
5. 5. Tramm R, Ilic D, Davies AR, Pellegrino VA, Romero L, Hodgson C. Extracorporeal membrane oxygenation for critically ill adults. Cochrane Database of Systematic Reviews. 2015;2015(1).
6. 6. Pavlushkov E, Berman M, Valchanov K. Cannulation techniques for extracorporeal life support. Annals of Translational Medicine. 2017;5(4):70.
7. 7. Savaş H, Köken ZÖ, Çelik ŞŞ. Extracorporeal membrane oxygenation and nursing care. Turkish Journal of Cardiovascular Nursing. 2021;12(28):126-133.
8. 8. Arslantaş M, Cinel İ, Günerli A. Sepsis and extracorporeal membrane oxygenation. Journal of the Turkish Society of Intensive Care. 2013;11.

9. 9. Squiers JJ, Lima B, DiMaio JM. Contemporary extracorporeal membrane oxygenation therapy in adults. Journal of Thoracic and Cardiovascular Surgery. 2016;152(1):20-32.
10. 10. Guan Y, Su X, McCoach R, et al. Mechanical performance comparison between Rotaflow and Centrimag pumps in an adult ECLS model. Perfusion. 2010;25(2):71-76.
11. 11. Bayar MK. Extracorporeal membrane oxygenation. Current Chest Diseases. 2018:93-103.
12. 12. Cingöz F, Tatar H. Extracorporeal membrane oxygenation in pediatric patients. Turkish Journal of Chest, Heart and Vessels. 2008;16:50-57.
13. 13. Gajkowski EF, Herrera G, Hatton L, et al. ELSO guidelines for adult and pediatric ECMO circuits. ASAIO Journal. 2022;68(2):133-152.
14. 14. Gündüz F, Arpa Y, Körkuş K, Keskin E, Yalçınbaş YK. Nursing care of pediatric patients undergoing ECMO in cardiac surgery. J Educ Res Nurs. 2016;13(2):72-78.
15. 15. Tonna JE, Selzman CH, Mallin MP, et al. Development of an emergency department ECMO program. Annals of Emergency Medicine. 2017;70(1):32-40.
16. 16. Mete EMT, Orhan G. National ECLS team organization and triage. Turkiye Klinikleri Cardiovascular Surgery-Special Topics. 2017;9(3):174-179.
17. 17. Yağdı T, Engin Ç, Atay Y, Ayık F, Özbaran M. Training of ECLS team members. Turkiye Klinikleri Cardiovascular Surgery-Special Topics. 2017;9(3):180-182.
18. 18. Barbaro RP, Paden ML, Guner YS, et al. Pediatric ELSO registry report 2016. ASAIO Journal. 2017;63(4):456-463.
19. 19. Basiewicz-Slaczka E, Wołoszczuk-Gebicka B, Yaqoub S, Kamiński A. Oxygenation index in congenital diaphragmatic hernia. Developmental Period Medicine. 2015;19(3Pt1):283-8.
20. 20. Brogan TV, Lequier L, Lorusso R, MacLaren G, Peek G. Extracorporeal Life Support: The ELSO Red Book. ELSO; 2017.
21. 21. Stiller B, Lemmer J, Merkle F, et al. Consumption of blood products during ECMO vs VAD in children. Intensive Care Medicine. 2004;30:1814-1820.
22. 22. Drews T, Stiller B, Hübler M, et al. Coagulation management in pediatric mechanical circulatory support. ASAIO Journal. 2007;53(5):640-645.
23. 23. Ayık MF, Işık O, Akyüz M, Atay Y. Use of ECMO in pediatric cardiac surgery. meEge Journal of Medicine. 2014;53(3):173-176.
24. 24. Duncan BW. Mechanical cardiac support in the young: ECMO. Seminars in Thoracic and Cardiovascular Surgery: Pediatric Cardiac Surgery Annual. 2006;9(1):75-82.
25. 25. Bergeron A, Holifield L. ECMO: Nurse’s role in patient care. Nursing Critical Care. 2020;15(3):6-14.
26. 26. Combes A, Mossadegh C, eds. Nursing Care and ECMO. Springer; 2017.
27. 27. Calhoun A. Nursing care of adult ECMO patients. Critical Care Nursing Quarterly. 2018;41(4):394-398.
28. 28. Van Kiersbilck C, Gordon E, Morris D. Ten things nurses should know about ECMO. Intensive Care Medicine. 2016;42:753-755.
29. 29. Bermede AO, Can ÖS, Alanoğlu Z. Analgesia, sedation and neuromuscular blockade in ECMO. Turkiye Klinikleri Cardiovascular Surgery-Special Topics. 2017;9(3):214-219.
30. 30. Verklan MT, Walden M. Core Curriculum for Neonatal Intensive Care Nursing. Elsevier; 2014.
31. 31. Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines: Parenteral nutrition in ICU. Clinical Nutrition. 2009;28(4):387-400.
32. 32. Sönmez Düzkaya D, Yakut T, Bozkurt G. Nursing care of a child undergoing ECMO: Case Report. J Educ Res Nurs. 2015;12(2).
33. 33. Redaelli S, Zanella A, Milan M, et al. Daily nursing care on VV-ECMO patients. Journal of Artificial Organs. 2016;19:343-349.
34. 34. Brechot N. Weaning process from VA-ECMO. In: Combes A, Mossadegh C, eds. Nursing Care and ECMO. Springer; 2017:93-95.
35. 35. Gardner M. Pediatric ECMO: Applications and outcomes. Journal of Pediatric Nursing. 2014;29(5):402-410.
36. 36. Sasson L, Cohen I, Tamir A, et al. ECMO in pediatric patients: 10-year experience. Israel Medical Association Journal. 2013;15(1):13-16.
37. 37. Buscher H, Vaidiyanathan S, Al-Soufi S, et al. Sedation practice in VV-ECMO. ASAIO Journal. 2013;59(6):636-641.
38. 38. Frenckner B. ECMO: A breakthrough for respiratory failure. Journal of Internal Medicine. 2015;278(6):586-598.
39. 39. Turner AD, Streb MM, Ouyang A, et al. Long-term neurobehavioral and functional outcomes of pediatric extracorporeal membrane oxygenation survivors. ASAIO J. 2024;70(5):409-416.
40. 40. Shappley RKH, Holder CM, Poplos CE, et al. Standardized therapies after ECMO program (STEP); a novel approach to pediatric post-ECMO care. J Extra Corpor Technol. 2024;56:94–100.